Business in Brief

Mobileye profits up sharply after IPO; Kamada crashes after clinical trials fail; Teva begins sales of hepatitis B generic; Hamashbir plans share sale; Bezek, banks lead TA-25 index higher.

comments Print
Mobileye profits up sharply after IPO